Search Results

Another look at MAO-B inhibitors in early Parkinson's disease

Source: Inpharma, Volume 1, Number 1455, 2004-09-18 , pp. 2-2(1)

Publisher: Adis International

Sarizotan reduces troublesome dyskinesia in levodopa recipients

Source: Inpharma, Volume 1, Number 1440, 2004-06-05 , pp. 7-7(1)

Publisher: Adis International

Sarizotan reduces troublesome dyskinesia in levodopa recipients

Source: Reactions, Volume 1, Number 1005, 2004-06-12 , pp. 4-4(1)

Publisher: Adis International

Rasagiline leads to less time in `off' state in PD

Source: Inpharma, Volume 1, Number 1441, 2004-06-12 , pp. 9-10(2)

Publisher: Adis International

Selegiline in its new formulation [Zydis] improves motor control in patients with Parkinson's disease

Source: Inpharma, Volume 1, Number 1441, 2004-06-12 , pp. 12-12(1)

Publisher: Adis International

A coffee a day keeps neurodegeneration away?

Source: Inpharma, Volume 1, Number 1437, 2004-05-15 , pp. 4-4(1)

Publisher: Adis International

PD clinic improves symptoms, but raises costs in Germany

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 450, 2004-04-10 , pp. 12-12(1)

Publisher: Adis International

PD clinic improves symptoms, but raises costs in Germany

Source: Inpharma, Volume 1, Numbers 1432-1433, 2004-04-10 , pp. 8-8(1)

Publisher: Adis International

Aripiprazole: Exacerbation of Parkinson's disease in an elderly patient: case report

Source: Reactions, Volume 1, Number 992, 2004 , pp. 6-7(2)

Publisher: Adis International

Treatment with once-daily transdermal rotigotine can improve Parkinsonian symptoms in patients with early Parkinson's Disease

Source: Inpharma, Volume 1, Number 1424, 2004 , pp. 10-10(1)

Publisher: Adis International

Pramipexole and pergolide show similar efficacy in PD

Source: Inpharma, Volume 1, Number 1420, 2004 , pp. 15-15(1)

Publisher: Adis International

PD costs rise with increasing disease severity, patient age

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 438, 2003 , pp. 7-7(1)

Publisher: Adis International

Embryonic stem cells correct parkinsonian mice

Source: Inpharma, Volume 1, Number 1412, 2003 , pp. 11-11(1)

Publisher: Adis International

Pramipexole in routine clinical practice

Source: Inpharma, Volume 1, Number 1412, 2003 , pp. 15-15(1)

Publisher: Adis International

Nefazodone appears to have antiparkinsonian activity

Source: Inpharma, Volume 1, Number 1412, 2003 , pp. 16-16(1)

Publisher: Adis International

The cholinesterase inhibitor rivastigmine may improve cognitive function in patients with Parkinson's disease and dementia

Source: Inpharma, Volume 1, Number 1412, 2003 , pp. 19-19(1)

Publisher: Adis International

What does istradefylline have to `off'er in PD?

Source: Inpharma, Volume 1, Number 1409, 2003 , pp. 8-8(1)

Publisher: Adis International

NSAIDs may prevent or delay Parkinson's disease

Source: Inpharma, Volume 1, Number 1410, 2003 , pp. 12-12(1)

Publisher: Adis International

Cabergoline warranted for PD in Germany vs levodopa

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 427, 2003 , pp. 3-3(1)

Publisher: Adis International

Cabergoline warranted for PD in Germany vs levodopa

Source: Inpharma, Volume 1, Number 1402, 2003 , pp. 4-4(1)

Publisher: Adis International